BIOMAT Database Logo BIOMAT Database Logo

The bleeding time as a screening test for evaluation of platelet function. 1972

L A Harker, and S J Slichter

UI MeSH Term Description Entries
D008297 Male Males
D011696 Purpura, Thrombocytopenic Any form of purpura in which the PLATELET COUNT is decreased. Many forms are thought to be caused by immunological mechanisms. Purpura, Thrombopenic,Purpuras, Thrombocytopenic,Purpuras, Thrombopenic,Thrombocytopenic Purpura,Thrombocytopenic Purpuras,Thrombopenic Purpura,Thrombopenic Purpuras
D001772 Blood Cell Count The number of LEUKOCYTES and ERYTHROCYTES per unit volume in a sample of venous BLOOD. A complete blood count (CBC) also includes measurement of the HEMOGLOBIN; HEMATOCRIT; and ERYTHROCYTE INDICES. Blood Cell Number,Blood Count, Complete,Blood Cell Counts,Blood Cell Numbers,Blood Counts, Complete,Complete Blood Count,Complete Blood Counts,Count, Blood Cell,Count, Complete Blood,Counts, Blood Cell,Counts, Complete Blood,Number, Blood Cell,Numbers, Blood Cell
D001780 Blood Coagulation Tests Laboratory tests for evaluating the individual's clotting mechanism. Coagulation Tests, Blood,Tests, Blood Coagulation,Blood Coagulation Test,Coagulation Test, Blood,Test, Blood Coagulation
D001791 Blood Platelet Disorders Disorders caused by abnormalities in platelet count or function. Thrombocytopathy,Blood Platelet Disorder,Disorder, Blood Platelet,Disorders, Blood Platelet,Platelet Disorder, Blood,Platelet Disorders, Blood,Thrombocytopathies
D001792 Blood Platelets Non-nucleated disk-shaped cells formed in the megakaryocyte and found in the blood of all mammals. They are mainly involved in blood coagulation. Platelets,Thrombocytes,Blood Platelet,Platelet,Platelet, Blood,Platelets, Blood,Thrombocyte
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001241 Aspirin The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5) Acetylsalicylic Acid,2-(Acetyloxy)benzoic Acid,Acetysal,Acylpyrin,Aloxiprimum,Colfarit,Dispril,Easprin,Ecotrin,Endosprin,Magnecyl,Micristin,Polopirin,Polopiryna,Solprin,Solupsan,Zorprin,Acid, Acetylsalicylic
D013921 Thrombocytopenia A subnormal level of BLOOD PLATELETS. Thrombopenia,Thrombocytopenias,Thrombopenias

Related Publications

L A Harker, and S J Slichter
The bleeding time as a preoperative screening test.
May 1985, The American journal of medicine,
L A Harker, and S J Slichter
The bleeding time as a test of hemostatic function.
July 1975, American journal of clinical pathology,
L A Harker, and S J Slichter
Screening women with menorrhagia for underlying bleeding disorders: the utility of the platelet function analyser and bleeding time.
September 2005, Haemophilia : the official journal of the World Federation of Hemophilia,
L A Harker, and S J Slichter
Evaluation of a whole blood remote platelet function test for the diagnosis of mild bleeding disorders.
May 2014, Journal of thrombosis and haemostasis : JTH,
L A Harker, and S J Slichter
W. W. Duke and his bleeding time test. A commentary on platelet function.
September 1983, JAMA,
L A Harker, and S J Slichter
The post-aspirin bleeding time: a screening test for evaluating haemostatic disorders.
December 1979, British journal of haematology,
L A Harker, and S J Slichter
The in-vitro bleeding time for the screening of platelet function in the newborn: assessment of a normal reference range.
March 2001, European journal of pediatrics,
L A Harker, and S J Slichter
[Bleeding time (Duke) as a clinical function test of the primary phase of hemostasis].
November 1976, Die Medizinische Welt,
L A Harker, and S J Slichter
[Ex-vivo bleeding time as a control for platelet transfusion].
January 1994, Beitrage zur Infusionstherapie und Transfusionsmedizin = Contributions to infusion therapy and transfusion medicine,
L A Harker, and S J Slichter
[Platelet propagation as a blood platelet function test].
October 1971, Die Medizinische Welt,
Copied contents to your clipboard!